Login / Signup

Editors' Note: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.

Ariane LewisSteven L Galetta
Published in: Neurology (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • newly diagnosed
  • nk cells
  • stem cells
  • mesenchymal stem cells
  • smoking cessation
  • cell therapy